Lista de obras - Olivier Nibourel - Dominio Público Uruguay

A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

artículo científico publicado en 2019

Absence of CALR mutations in JAK2-negative polycythemia.

artículo científico publicado en 2016

Acquired alpha thalassemia myelodyslastic/myeloproliferative syndrome (ATMDS): evolution on hypomethylating agent therapy

artículo científico publicado en 2011

Acquisition of genomic events leading to lymphoblastic transformation in a rare case of myeloproliferative neoplasm with BCR-JAK2 fusion transcript.

artículo científico publicado en 2016

Acute myeloid leukemia with translocation t(3;5): new molecular insights.

artículo científico publicado en 2013

C/EBPA methylation is common in T-ALL but not in M0 AML.

artículo científico publicado en 2009

C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations

artículo científico publicado en 2010

Calibration of BCR-ABL1 mRNA quantification methods using genetic reference materials is a valid strategy to report results on the international scale

artículo científico publicado en 2014

Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial

artículo científico publicado en 2014

Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group.

artículo científico publicado en 2018

Comprehensive molecular landscape in patients older than 80 years old diagnosed with acute myeloid leukemia: a study of the French Hauts-de-France AML observatory

article

Cooperating gene mutations in acute myeloid leukemia: a review of the literature.

artículo científico publicado en 2008

Copy-number analysis identified new prognostic marker in acute myeloid leukemia

artículo científico publicado en 2016

Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia

artículo científico publicado en 2011

Disease escape with the selective loss of the Philadelphia chromosome after tyrosine kinase inhibitor exposure in Ph-positive acute lymphoblastic leukemia

scientific article published on 27 January 2020

Familial myeloid malignancies with germline TET2 mutation

scientific article published on 11 December 2019

Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations.

artículo científico publicado en 2014

Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia

artículo científico publicado en 2015

Genomic characterization of Imatinib resistance in CD34+ cell populations from chronic myeloid leukaemia patients

artículo científico publicado en 2010

High-throughput genomic analysis in Waldenström's macroglobulinemia

scientific article published on February 2011

IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association

artículo científico publicado en 2015

Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML

artículo científico publicado en 2017

Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia.

artículo científico publicado en 2014

Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission.

artículo científico publicado en 2010

Inherited transmission of the CSF3R T618I mutational hotspot in familial chronic neutrophilic leukemia

scientific article published on 01 December 2019

MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin

artículo científico publicado en 2014

MYD88 L265P mutation in Waldenstrom macroglobulinemia.

artículo científico publicado en 2013

Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemia.

artículo científico publicado en 2016

Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia.

artículo científico publicado en 2011

Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA

artículo científico publicado en 2014

Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine

artículo científico publicado en 2015

Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia

artículo científico publicado en 2011

Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions

artículo científico publicado en 2011

Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia

artículo científico publicado en 2015

Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With NPM1 Mutation: A Study by the Acute Leukemia French Association Group.

artículo científico publicado en 2016

Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association

artículo científico publicado en 2012

Quantification of EVI1 transcript levels in acute myeloid leukemia by RT-qPCR analysis: A study by the ALFA Group.

artículo científico publicado en 2015

Quantification of JAK2V617F mutation by next-generation sequencing technology.

artículo científico publicado en 2013

Recurrent in-frame insertion in C/EBPα TAD2 region is a polymorphism without prognostic value in AML

artículo científico publicado en 2007

TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML.

artículo científico publicado en 2017

TP53 mutation and its prognostic significance in Waldenstrom's Macroglobulinemia

artículo científico publicado en 2017

Waved aCGH: to smooth or not to smooth.

artículo científico publicado en 2010

Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association

artículo científico publicado en 2009

Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemia

artículo científico publicado en 2011

Lista de obras de Olivier Nibourel

A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

Absence of CALR mutations in JAK2-negative polycythemia.

Acquired alpha thalassemia myelodyslastic/myeloproliferative syndrome (ATMDS): evolution on hypomethylating agent therapy

Acquisition of genomic events leading to lymphoblastic transformation in a rare case of myeloproliferative neoplasm with BCR-JAK2 fusion transcript.

Acute myeloid leukemia with translocation t(3;5): new molecular insights.

C/EBPA methylation is common in T-ALL but not in M0 AML.

C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations

Calibration of BCR-ABL1 mRNA quantification methods using genetic reference materials is a valid strategy to report results on the international scale

Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial

Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group.

Comprehensive molecular landscape in patients older than 80 years old diagnosed with acute myeloid leukemia: a study of the French Hauts-de-France AML observatory

Cooperating gene mutations in acute myeloid leukemia: a review of the literature.

Copy-number analysis identified new prognostic marker in acute myeloid leukemia

Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia

Disease escape with the selective loss of the Philadelphia chromosome after tyrosine kinase inhibitor exposure in Ph-positive acute lymphoblastic leukemia

Familial myeloid malignancies with germline TET2 mutation

Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations.

Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia

Genomic characterization of Imatinib resistance in CD34+ cell populations from chronic myeloid leukaemia patients

High-throughput genomic analysis in Waldenström's macroglobulinemia

IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association

Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML

Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia.

Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission.

Inherited transmission of the CSF3R T618I mutational hotspot in familial chronic neutrophilic leukemia

MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin

MYD88 L265P mutation in Waldenstrom macroglobulinemia.

Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemia.

Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia.

Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA

Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine

Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia

Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions

Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia

Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With NPM1 Mutation: A Study by the Acute Leukemia French Association Group.

Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association

Quantification of EVI1 transcript levels in acute myeloid leukemia by RT-qPCR analysis: A study by the ALFA Group.

Quantification of JAK2V617F mutation by next-generation sequencing technology.

Recurrent in-frame insertion in C/EBPα TAD2 region is a polymorphism without prognostic value in AML

TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML.

TP53 mutation and its prognostic significance in Waldenstrom's Macroglobulinemia

Waved aCGH: to smooth or not to smooth.

Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association

Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemia